Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $203.51 Billion |
|---|---|
| Enterprise Value | $298.19 Billion |
| Earnings per Share | $-101 |
| Beta | 0.28 |
| Outstanding Shares | 31,848,000 |
| P/E Ratio | -6.96 |
|---|---|
| PEG | 0.6 |
| Price to Sales | 1.29 |
| Price to Book Ratio | 1.26 |
| Enterprise Value to Revenue | 1.9 |
| Enterprise Value to EBIT | -12.71 |
| Enterprise Value to Net Income | -11 |
| Total Debt to Enterprise | 0.43 |
| Debt to Equity | 0.8 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
BINEX Co., Ltd. operates as a pharmaceutical enterprise based in South Korea. The company provides an extensive array of medicinal products, encompassing bisroot items, gastrointestinal treatments (including antispasmodics and antiulcera...